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INTRODUCTION
Acute uncomplicated cystitis (AUC) is the most commonly
encountered bacterial infections in healthy women and fluo-
roquinolone treatment has been a standard therapy for it (1).
However, a trend toward increasing drug resistance among
Escherichia coli (E. coli) has complicated the treatment of AUC
over the past few years (2). 
Most of these infections are caused by distinctive E. coli
strains, and these strains possess virulence factors (VFs) to
overcome host defenses and injure or invade host tissues so
that the E. coli persist and multiply within the host’s urinary
tract (3). Several investigations have shown that the cipro-
floxacin resistant E. coli strains (CFRE) display overall reduced
virulence, whereas the ciprofloxacin susceptible E. coli strains
(CFSE) are more virulent (4-7). Some epidemiological stud-
ies have also reported that CFRE isolates exhibit a different
phylotype than do their susceptible counterparts. However,
the previous studies have major limitations for their findings
to be generally accepted. First of all, the small numbers of
the CFRE isolates may limit the ability to characterize the
resistant strains because of the increased likelihood of type I
and II errors (7). Second, because the expression patterns of
VF and the phylotyping are different among different coun-
tries, the isolates from western countries have some limita-
tions to explain the phylotyping and VFs in Asia. For exam-
ple, Russian urinary tract infection isolates belonged more
often to phylogenetic group A and they possessed fewer vir-
ulence genes than did the Norwegian isolates (9, 10). Third,
the available studies were a mix of data from uncomplicated
and complicated cystitis. However, the characteristics of AUC
are different from the complicated cystitis according to the
antibiotic resistance, the drug treatment responses and the
associated diseases. We must separately characterize the two
patterns of cystitis in a study that focuses on their phylotyp-
ing and their virulence expressions. Fourth, the absence of the
clinical or epidemiological data of the host in the previous
studies does not allow assessing the impact of the host on cer-
tain VF profiles or on the phylotyping from the infection. 
To clarify the clinical characteristics of the ciprofloxacin
resistance in patients with AUC, we analyzed the VFs, the
resistance phenotype and the clinical characteristics for 54
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Virulence Characteristics and Phylogenetic Background of Ciprofloxacin
Resistant Escherichia coli in the Urine Samples from Korean Women
with Acute Uncomplicated Cystitis
To clarify the characteristics of the virulence factors (VFs) of ciprofloxacin resistant
Escherichia coli (CFRE) with acute uncomplicated cystitis (AUC), we determined
the VFs and the phylogenetic background of all 54 CFRE strains and the 55 random-
ly selected ciprofloxacin sensitive E. coli strains (CFSE) from patients with AUC in
22 Korean hospitals. The prevalence of the VFs was as follows: fimA, papEF, pap-
GIII, sfaI, dafaBC, cnf1, and hlyA were presented in 96%, 54%, 68%, 91%, 49%,
72%, and 29% of the samples, respectively. The expressions of papEF, cnf1, and
hlyA were significantly more prevalent in the CFSE. Moreover, the expressions of
cnf, and papEF significantly reduced the risk of ciprofloxacin resistance. The CFSE
was also marginally associated with the group B2 (P=0.05). Although the presence
of pyuria and a previous cystitis history were not related with the phylotyping and
the expressions of VFs, group B2, and fimA and papEF were more expressed in
the younger age patients (P<0.05). In conclusion, the CFRE exhibits a selective
loss of VFs and the non-B2 phylotype in Korean AUC patients. The group B2 and
the presence of fimA and papEF are associated with a younger age of AUC patients. 
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samples of ciprofloxacin resistant strains from patients with
AUC and 55 randomly selected ciprofloxacin sensitive strains
from patients with AUC in 22 Korean hospitals. 
MATERIALS AND METHODS
Patients and the bacterial isolates 
All the female patients between 18 and 65 yr old and who
presented with symptoms of dysuria, urgency, frequency or
a combination of these between May and October 2006 were
included in this study. The exclusion criteria were symptoms
of or predisposing factors for complicated cystitis. These women
presented to outpatient urological clinics and they were not
hospitalized. The women who had received antimicrobial
agents in the 4 weeks previous to the study were excluded.
A clean-catch midstream urine sample was examined for the
presence of leukocytes by microscopy, and then it was sent to
a central laboratory for culture. Only one specimen per pati-
ent was accepted. No mixed infections were accepted. The
E. coli included in the study were from cultures yielding ≥103
colony forming unit (CFU)/mL (2). 
In total, 225 E. coli isolates were prospectively collected from
the urine samples of the female outpatients with uncompli-
cated cystitis in 22 hospitals of Korea. The minimum inhi-
bitory concentration (MIC) of ciprofloxacin resistance was
determined by the agar dilution method on Mueller-Hin-
ton agar (Becton, Dickinson and Company, Franklin Lakes,
NJ, USA) as recommended by the NCCLS (2). All 54 sam-
ples with ciprofloxacin resistance and the 55 randomly select-
ed ciprofloxacin sensitive samples were included. For the total
109 isolated samples, 6 of the patients’ medical records were
not available for clinical data analysis. The numbers of white
blood cells (WBC) in the urine were dichotomized into 1-4
WBC and ≤5 WBC per high power field. The numbers of
cases of recurrent cystitis were also dichotomized into no recur-
rence and recurrence within a year after the first bout of AUC. 
Virulence genotypes and phylotyping
One E. coli colony was harvested from the characterized
plate and the bacteria were grown at 37℃ in Luria-Bertani
broth. The bacterial DNA was extracted by using the Wiz-
ard Genomic DNA Purification kit (Promega, Madison, WI,
USA). The E. coli isolates were grouped into phylogenetic
biotypes (A, B1, B2, and D) according to the presence of the
chuA and yjaA genes and TspE4.C2 by performing multiplex
polymerase chain reaction (PCR) (Table 1) (11). PCR was per-
formed with 25 mL of the following reaction mixture: 12.5 mL
of 2 times GoTaq Green Master mixture (Promega), 20 pM
of each primer and 1 mL of the DNA template. The amplifi-
cation conditions were as follows: each step consisted of 95℃
for 30 sec, 55℃ for 30 sec and 72℃ for 30 sec, and there
was a final extension step of 7 min at 72℃. Thirty cycles were
performed for amplification.
We also examined for 7 VFs (fimA, papGIII, papEF, cnf1,
hlyA, sfaI, and dafaBC) by performing a single polymerase
chain reaction (Table 1). The amplification conditions were
as follows: each step consisted of denaturation at 95℃ for
30 sec, annealing at 53℃ for fimA and papGIII, 55℃ for
cnf1, 57℃ for hlyA, papEF, and sfaI, and 59℃ for 30 sec for
dafaBC and extension at 72℃ for 30 sec. Twenty five-thir-
ty cycles were performed for amplification.
Statistical analysis 
Statistical analysis was performed by using Fisher’s exact
test, chi-square tests, Student’s t-tests and the Mann-Whit-
ney test. Multiple variables were assessed as predictors of the
categorical outcomes by multivariable logistic regression anal-
ysis. Pvalues ≤0.05 were considered statistically significant. 
RESULT
The prevalence of VFs were as follows; fimA,papEF, papGIII,
sfaI,dafaBC,cnf1, and hlyA was present in 96%, 54%, 68%,
91%, 49%, 72%, and 29% of the samples, respectively (Fig.
1). The expressions of papEF, cnf1, and hlyA were significantly
more prevalent in the CFSE than in the CFRE (P=0.007,
P=0.018, P=0.011, respectively), whereas the expression of
fimA, dafaBC, papGIII, and sfaI were not (P=0.346, P=1.0,
P=0.839, P=0.514, respectively) (Table 2). The phylotype
B2, D, A, and B1 was present in 57%, 26%, 16%, and 1%
Genes Primer sequences 
ChuA.1 5′ -GACGAACCAACGGTCAGGAT-3′
ChuA.2 5′ -TGCCGCCAGTACCAAAGACA-3′
YjaA.1 5′ -TGAAGTGTCAGGAGACGCTG-3′
YjaA.2 5′ -ATGGAGAATGCGTTCCTCAAC-3′
TspE4C2.1 5′ -GAGTAATGTCGGGGCATTCA-3′
TspE4C2.2 5′ -CGCGCCAACAAAGTATTACG-3′
cnf1 5′ -AAGATGGAGTTTCCTATGCAGGAG-3′
5′ -CATTCAGAGTCCTGCCCTCATTATT-3′
hlyA 5′ -AACAAGGATAAGCACTGTTCTGGCT-3′
5′ -ACCATATAAGCGGTCATTCCCGTCA-3′
fimA 5′ -GTTGTTCTGTCGGCTCTGTC-3′
5′ -ATGGTGTTGGTTCCGTTATTC-3′
papGIII 5′ -CATTTATCGTCCTCAACTTAG-3′
5′ -AAGAAGGGATTTTGTAGCGTC-3′
papEF 5′ -AGAGAGAGCCACTCTTATACGGACA-3′
5′ -GCAACAGCAACGCTGGTTGCATCAT-3′
sfaI 5′ -CGGAGGAGTAATTACAAACCTGGCA-3′
5′ -CTCCGGAGAACTGGGTGCATCTTAC-3′
dafaBC 5′ -CATCAAGCTGTTTGTTCGTCCGCCG-3′
5′ -GCTGGGCAGCAAACTGATAACTCTC-3′
Table 1. Primers for the virulence genotypes and the phylotyp-
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of the samples, respectively (Fig. 1). The CFSE was marginal-
ly associated with the group B2 (P=0.05) (Table 2). Presence
of pyuria and a previous history of AUC within the recent
year were not related with the phylotyping and the all viru-
lence factors (Table 3). The expressions of phylotype groups
B2, papEF, and fimA were associated with a lower absolute
patient age (P=0.03, P=0.002, P=0.03, respectively) (Table
4). On the logistic regression model, the expressions of cnf1
and papEF reduced the ciprofloxacin resistance risk (odds ratio
[OR] 0.237, 95% confidence interval [CI] 0.07-0.79 for cnf1;
OR 0.40, 95% CI 0.16-0.96 for papEF) (Table 5). However,
the phylogenetic background did not increase the risk of
ciprofloxacin resistance (OR 1.843, 95% CI 0.766-4.437,
P=0.173) (Table 5). 
M
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Fig. 1. Examples of single PCR for detecting virulence factors (A) and multiplex PCR for phylotyping (B). 
M, 100 bp marker. 
Factors
Ciprofloxacin
sensitive strain
(n=57) (%)
Ciprofloxacin
resistant strain
(n=52) (%)
P value
P value
Virulence factor
fimA 56 (98) 49 (94) 0.346
papEF 38 (67) 21 (40) 0.007
papGIII 38 (67) 36 (69) 0.839 
sfaI 53 (93) 46 (88) 0.514
dafaBC 28 (49) 25 (48) 1.00
cnf1 47 (82) 32 (61) 0.018      
hlyA 23 (40) 9 (17) 0.011  
Phylotyping
B2 38 (67) 25 (48) 0.05   
Table 2. The expression of virulence factors and phylotyping
results in the ciprofloxacin sensitive and resistant E. coli strains
that caused acute uncomplicated cystitis
Bacterial
factors 
Patient characteristics
Pyuria (WBC/HPF)
1-4≤
(n=34) 
≥5
(n=69) 
Recurrence
Yes
(n=26)
No
(n=77)
Virulence factor
fimA 33 (97) 68 (98) 26 (100) 75 (97)
papEF 16 (47) 43 (62) 13 (50) 46 (60)
papGIII 21 (62) 49 (71) 18 (69) 52 (67)
sfaI 30 (88) 64 (93) 23 (88) 71 (92)
dafaBC 19 (56) 32 (46) 13 (50) 38 (49)
cnf1 25 (73) 51 (74) 17 (65) 59 (76)
hlyA 10 (29) 22 (32) 7 (27) 25 (32)
Phylotyping
B2 22 (65) 36 (52) 13 (50) 45 (58)
Table 3. Association between bacterial characteristics and host
characteristics
Data are no. (%) of isolates.
CI, confidence interval.  
Factors
Age distribution (yr, mean±SD)
Positive Negative
Virulence factors
fimA 45.39±12.61 63.5±0.7 0.046
papEF 42.47±12.59 50.13±11.69 0.002
papGIII 46.62±12.04 43.87±14.13 0.309
sfaI 45.45±12.91 48.77±11 0.458
dafaBC 47.13±12.58 44.38±12.86 0.275
cnf1 45.47±12.76 46.51±12.89 0.716
hlyA 47.65±11.56 44.88±13.22 0.310
Phylogenetic background
B2 43.39±13.53
Others (A, D, B1) 48.77±11.06 0.033 
Ciprofloxacin
Resistance 48.04±11.09 
Sensitive 43.66±13.84 0.082
Table 4. Patient age and the characteristics of the E. coli isolates
(univariate analysis)
P value Odds ratio Risk factors
95% CI
Upper Lower
Serotype 1.843 0.766 4.437 0.173
cnf1 0.237 0.07 0.796 0.02
fimA 0.708 0.057 8.758 0.788
papGIII 2.91 0.913 9.27 0.071
hlyA 0.434 0.157 1.196 0.107
papEF 0.397 0.164 0.965 0.041
sfaI 1.198 0.272 5.275 0.812
dafaBC 0.93 0.395 2.193 0.869
Table 5. Multivariate analysis of the risk factors for ciprofloxacin
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DISCUSSION
This study was a prospective nation-wide study that was
conducted to evaluate the antibiotic resistance of E. coli iso-
lates from Korean AUC patients (2). We applied strict crite-
ria for selecting the isolates. The exclusion criteria were symp-
toms of or predisposing factors for complicated urinary tract
infections such as pregnancy, symptoms lasting longer than
7 days, fever, known urological or nephrological problems,
and more than 4 recurrences in the previous year (2). 
The previous data has shown that among human clinical
E. coli isolates, resistance to ciprofloxacin is associated with
decreased virulence and phylogenetic groups B2 (3-8). If this
is true, the E. coli isolates in areas with a higher prevalence
of ciprofloxacin resistance should show a lower incidence of
virulence factors. 
It is known that the expressions of VFs and phylotypes are
different between nearby or remote countries (9, 10, 12). The
fluoroquinolone resistance by E. coli is highly detected most-
ly in the Asia-Pacific area. Moreover, ciprofloxacin should be
reconsidered in some Asian countries as a first line treatment
for recurrent cystitis (2, 13, 14). However, there is little data
about the expressions of VFs and the phylotypes in E. coli iso-
lates from Asian patients with AUC. 
fimA was found in about 96% of the E. coli strains in our
study. The high prevalence of fimA is in accordance with the
studies conducted by other investigators (4, 15). Our results
showed that the proportions of fimA among the ciprofloxacin
resistant isolates and the ciprofloxacin sensitive isolates were
not different. 
P-fimbriation is a characteristic of the strains that cause
upper urinary tract infections. Each P-fimbriation is composed
of a major subunit papA and minor adherence-related fimbri-
al subunits such as papE, papF, and papG. These fimbrial pro-
teins are encoded by a chromosomal multicistronic gene clus-
ter termed pap. We amplified the partial gene sequence of
papE and papF because it is well known that the results of
gene sequencing papEF are very similar or identical to those
shown for other pap families for ciprofloxacin resistance (8).
The expression of papEF was significantly more prevalent in
the ciprofloxacin sensitive isolates. In addition, the expres-
sion of papEF significantly reduced the ciprofloxacin resis-
tance risk (OR 0.40, 95% CI 0.16-0.96 for papEF). The result
of our study on the papEF expression was well matched with
other previous studies (6, 7).
The Prs (pap-related substance) adhesin variant, which is
also known as Class III G adhesin or the papG variant III, is
usually the predominant papG variant among the E. coli iso-
lates from women and children with cystitis (16). Even though
the protein sequences between papG and papGIII were very
similar (94% match in protein sequences with the BLAST
analysis), there was no correlation between the expressions
of papEF and papGIII (P=0.199). In addition, the expression
of papGIII in our study was not associated with ciprofloxacin
resistance. The relative high expression of papGIII (67.8%)
in our study is noteworthy. Ruiz et al. (17) reported that the
expression of papGIII was lower among isolates that caused
cystitis than our study. We do not know by what mechanisms
the difference was caused. But a geographically uneven dis-
tribution of papGIII or the differences of the patients’ disease
status may have contributed to the dissimilarity of papIII ex-
pression. In this respect, there was a significant correlation
in our study between the presence of the papGIII gene and
the presence of genes encoding cnf1 and hylA (P=0.000, P=
0.006, respectively). Our results were very similar with the
report of Ruiz et al. (17) reporting that there was a 100%
association between the presence of the papGIII gene and the
presence of alpha-hemolysin and necrotizing factor type 1.
cnf1 (cytotoxic necrotizing factor type 1) belongs to a group
of bacterial necrotic substances that destroy host cells. E. coli
also produce hemolysins, which are cytotoxic due to the for-
mation of transmembranous pores in host cell membranes
(18). In addition to lysing erythrocytes, hemolysin is toxic
to a range of host cells in ways that probably contribute to
inflammation, tissue injury and impaired host defenses. Our
results showed that the genes encoding hemolysin and cnf1
among the CFSE strains were more prevalent than the CFRE
strains. 
Afa gene clusters encoding a-fimbrial adhesion are frequent-
ly found in E. coli causing intestinal and urinary tract infec-
tions. Members of the S-fimbrial family of adhesins are fre-
quently expressed in the extraintestinal E. coli strains isolat-
ed from men (3). This adhesion family consists of S-fimbriae
(Sfa), with its subtypes SfaI and SfaII. In our study, the dafaBC
and sfaI gene did not exhibit any trend for virulence-associ-
ated ciprofloxacin resistance. 
Interestingly, the incidences of virulence factors were high
when compared with those of other studies (6, 7, 9). This
finding is not similar with the rule ‘‘quinolone-resistant uro-
pathogenic E. coli are less virulent’’. This dissimilar result may
not be derived from technical incompetence. Many studies
have used the multiplex PCR for determining the expression
of virulence factors (15, 17), which was sometimes difficult
to define a specific band according to each virulence factor.
Practically, some studies have used a multiplex PCR first and
then hybridized amplified products with a specific sequence
product in order to obtain high specificity (8, 19). In our study,
we did not use multiplex PCR because of the presence of non-
specific bands and the small differences among the specific
bands (for example papEF, sfaI, and fimA in Fig. 1). We did
a single test ‘‘one PCR process for one virulence factor’’. Al-
though time consuming, this test is easy and accurate (6). We
duplicated the experiment using 20% of the samples. 
In the present work, 109 E. coli isolates were classified into
4 phylogenetic groups via polymerase chain reaction: 63 group
B2, 17 group A, 28 group D and 1 group B1. Of 63 group
B2 isolates, 38 revealed ciprofloxacin sensitivity, whereas 25
revealed ciprofloxacin resistance. Of 17 group A isolates, 8606 C.S. Kim, M.E. Kim, Y.-H. Cho, et al.
revealed ciprofloxacin sensitivity, while 9 revealed ciproflo-
xacin resistance. Of 28 group D isolates, 11 revealed cipro-
floxacin sensitivity, whereas 17 revealed ciprofloxacin resis-
tance. One isolate of group B1 sample revealed ciprofloxacin
resistance. Among the ciprofloxacin resistant E. coli isolates,
the shift toward the non-B2 phylogenetic groups (notably,
groups A, D and B1) was noted. 
Local inflammatory manifestations such as dysuria, frequen-
cy, lower abdominal pain together and pyuria are noted in
the cases with AUC. Some AUC patients have a tendency of
recurrent cystitis. Few studies have yet examined the expres-
sion of virulence factors and the characteristics of patients
with AUC. We examined the associations between VFs and
the patient characteristics as age, concomitant pyuria and a
previous cystitis history within the recent year. Pyuria and a
previous cystitis history were related neither with the phylo-
typing result nor with the VFs. The expressions of the phy-
lotype group B2, papEF and fimA were found to be associat-
ed with a lower absolute patient age. Ciprofloxacin resistance
was not related with the patients’ ages in our study (Table 4).
Unlike our study result, it is well known that an old age group
above 65 yr showed a tendency for antibiotic resistance as well
as a tendency of asymptomatic or less symptomatic infections
(20, 21). The difference may be a result of different age com-
position and a strict guideline to exclude the complicated
UTI in this study. 
In conclusion, the ciprofloxacin resistant E. coli isolates from
patients with acute uncomplicated cystitis exhibit the non-
B2 phylotype and a selective loss of virulence factors in Korea. 
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